{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:38:49Z","timestamp":1794512329476,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1038\/s41401-023-01054-1","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T07:03:18Z","timestamp":1679641398000},"page":"1687-1700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases"],"prefix":"10.1038","volume":"44","author":[{"given":"Hao-yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-gen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-yue","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-lan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"1054_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"1054_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4049\/jimmunol.1202737","volume":"190","author":"Y He","year":"2013","unstructured":"He Y, Franchi L, Nunez G. TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol. 2013;190:334\u20139.","journal-title":"J Immunol"},{"key":"1054_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.abb.2019.01.031","volume":"670","author":"Z Szekanecz","year":"2019","unstructured":"Szekanecz Z, Szamosi S, Kovacs GE, Kocsis E, Benko S. The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout. Arch Biochem Biophys. 2019;670:82\u201393.","journal-title":"Arch Biochem Biophys"},{"key":"1054_CR4","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3389\/fimmu.2018.02566","volume":"9","author":"L Mao","year":"2018","unstructured":"Mao L, Kitani A, Strober W, Fuss IJ. The role of NLRP3 and IL-1beta in the pathogenesis of inflammatory bowel disease. Front Immunol. 2018;9:2566.","journal-title":"Front Immunol"},{"key":"1054_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:588\u2013606.","journal-title":"Nat Rev Drug Discov"},{"key":"1054_CR6","doi-asserted-by":"publisher","first-page":"e13124","DOI":"10.1111\/sji.13124","volume":"95","author":"M Kinra","year":"2022","unstructured":"Kinra M, Nampoothiri M, Arora D, Mudgal J. Reviewing the importance of TLR-NLRP3-pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors. Scand J Immunol. 2022;95:e13124.","journal-title":"Scand J Immunol"},{"key":"1054_CR7","doi-asserted-by":"publisher","first-page":"879021","DOI":"10.3389\/fnagi.2022.879021","volume":"14","author":"HM Blevins","year":"2022","unstructured":"Blevins HM, Xu Y, Biby S, Zhang S. The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases. Front Aging Neurosci. 2022;14:879021.","journal-title":"Front Aging Neurosci"},{"key":"1054_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2007.07.009","volume":"130","author":"FR Greten","year":"2007","unstructured":"Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell. 2007;130:918\u201331.","journal-title":"Cell."},{"key":"1054_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden MS, Ghosh S. NF-kappaB in immunobiology. Cell Res. 2011;21:223\u201344.","journal-title":"Cell Res"},{"key":"1054_CR10","doi-asserted-by":"publisher","first-page":"652860","DOI":"10.3389\/fphar.2021.652860","volume":"12","author":"CC Su","year":"2021","unstructured":"Su CC, Wang SC, Chen IC, Chiu FY, Liu PL, Huang CH, et al. Zerumbone suppresses the LPS-induced inflammatory response and represses activation of the NLRP3 inflammasome in macrophages. Front Pharmacol. 2021;12:652860.","journal-title":"Front Pharmacol"},{"key":"1054_CR11","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1136\/ard.2011.152728","volume":"70","author":"JB Kuemmerle-Deschner","year":"2011","unstructured":"Kuemmerle-Deschner JB, Hachulla E, Cartwright R, Hawkins PN, Tran TA, Bader-Meunier B, et al. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. Ann Rheum Dis. 2011;70:2095\u2013102.","journal-title":"Ann Rheum Dis"},{"key":"1054_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","volume":"25","author":"CA Dinarello","year":"2013","unstructured":"Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol. 2013;25:469\u201384.","journal-title":"Semin Immunol"},{"key":"1054_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00253-015-7114-z","volume":"100","author":"MT Suzuki","year":"2016","unstructured":"Suzuki MT, Parrot D, Berg G, Grube M, Tomasi S. Lichens as natural sources of biotechnologically relevant bacteria. Appl Microbiol Biotechnol. 2016;100:583\u201395.","journal-title":"Appl Microbiol Biotechnol"},{"key":"1054_CR14","doi-asserted-by":"publisher","first-page":"e202200134","DOI":"10.1002\/cbdv.202200134","volume":"19","author":"M Mendili","year":"2022","unstructured":"Mendili M, Khadhri A, Mediouni-Ben Jemaa J, Andolfi A, Tufano I, Aschi-Smiti S, et al. Anti-inflammatory potential of compounds isolated from tunisian lichens species. Chem Biodivers. 2022;19:e202200134.","journal-title":"Chem Biodivers"},{"key":"1054_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1021\/np9803777","volume":"62","author":"KC Kumar","year":"1999","unstructured":"Kumar KC, Muller K. Lichen metabolites. 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism. J Nat Prod. 1999;62:817\u201320.","journal-title":"J Nat Prod"},{"key":"1054_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.fitote.2009.03.003","volume":"80","author":"TS Bugni","year":"2009","unstructured":"Bugni TS, Andjelic CD, Pole AR, Rai P, Ireland CM, Barrows LR. Biologically active components of a Papua New Guinea analgesic and anti-inflammatory lichen preparation. Fitoterapia. 2009;80:270\u20133.","journal-title":"Fitoterapia."},{"key":"1054_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1590\/S1984-82502011000400024","volume":"47","author":"MGD de Melo","year":"2011","unstructured":"de Melo MGD, Araujo AAD, Serafini MR, Carvalho LF, Bezerra MS, Ramos CS, et al. Anti-inflammatory and toxicity studies of atranorin extracted from Cladina kalbii Ahti in rodents. Braz J Pharm Sci. 2011;47:861\u201372.","journal-title":"Braz J Pharm Sci"},{"key":"1054_CR18","doi-asserted-by":"publisher","first-page":"e1986","DOI":"10.21769\/BioProtoc.1986","volume":"6","author":"H Shi","year":"2016","unstructured":"Shi H, Murray A, Beutler B. Reconstruction of the mouse inflammasome system in HEK293T cells. Bio Protoc. 2016;6:e1986.","journal-title":"Bio Protoc"},{"key":"1054_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248\u201355.","journal-title":"Nat Med"},{"key":"1054_CR20","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundback T, Nordlund P, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc. 2014;9:2100\u201322.","journal-title":"Nat Protoc"},{"key":"1054_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","volume":"1263","author":"MY Pai","year":"2015","unstructured":"Pai MY, Lomenick B, Hwang H, Schiestl R, McBride W, Loo JA, et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol Biol. 2015;1263:287\u201398.","journal-title":"Methods Mol Biol"},{"key":"1054_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fimmu.2013.00333","volume":"4","author":"Y Zhong","year":"2013","unstructured":"Zhong Y, Kinio A, Saleh M. Functions of NOD-like receptors in human diseases. Front Immunol. 2013;4:333.","journal-title":"Front Immunol"},{"key":"1054_CR23","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00018-016-2396-6","volume":"74","author":"F Hoss","year":"2017","unstructured":"Hoss F, Rodriguez-Alcazar JF, Latz E. Assembly and regulation of ASC specks. Cell Mol Life Sci. 2017;74:1211\u201329.","journal-title":"Cell Mol Life Sci"},{"key":"1054_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341:84\u201387.","journal-title":"Science."},{"key":"1054_CR25","doi-asserted-by":"publisher","first-page":"21984","DOI":"10.1073\/pnas.0910040106","volume":"106","author":"B Lomenick","year":"2009","unstructured":"Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S, et al. Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci USA. 2009;106:21984\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1054_CR26","doi-asserted-by":"publisher","first-page":"28309","DOI":"10.1074\/jbc.C100250200","volume":"276","author":"JL Poyet","year":"2001","unstructured":"Poyet JL, Srinivasula SM, Tnani M, Razmara M, Fernandes-Alnemri T, Alnemri ES. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem. 2001;276:28309\u201313.","journal-title":"J Biol Chem"},{"key":"1054_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.chembiol.2017.12.013","volume":"25","author":"MC Okondo","year":"2018","unstructured":"Okondo MC, Rao SD, Taabazuing CY, Chui AJ, Poplawski SE, Johnson DC, et al. Inhibition of Dpp8\/9 activates the Nlrp1b inflammasome. Cell Chem Biol. 2018;25:262\u20137.e265.","journal-title":"Cell Chem Biol"},{"key":"1054_CR28","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.4049\/jimmunol.180.11.7147","volume":"180","author":"P Pelegrin","year":"2008","unstructured":"Pelegrin P, Barroso-Gutierrez C, Surprenant A. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol. 2008;180:7147\u201357.","journal-title":"J Immunol"},{"key":"1054_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/imr.12618","volume":"281","author":"J Lugrin","year":"2018","unstructured":"Lugrin J, Martinon F. The AIM2 inflammasome: sensor of pathogens and cellular perturbations. Immunol Rev. 2018;281:99\u2013114.","journal-title":"Immunol Rev"},{"key":"1054_CR30","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41423-021-00683-y","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, He H, Lin B, Chen Y, Deng X, Jiang W, et al. RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. Cell Mol Immunol. 2021;18:1425\u201336.","journal-title":"Cell Mol Immunol"},{"key":"1054_CR31","doi-asserted-by":"publisher","first-page":"e134601","DOI":"10.1172\/jci.insight.134601","volume":"6","author":"G Xu","year":"2021","unstructured":"Xu G, Fu S, Zhan X, Wang Z, Zhang P, Shi W, et al. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight. 2021;6:e134601.","journal-title":"JCI Insight"},{"key":"1054_CR32","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","volume":"115","author":"C Marchetti","year":"2018","unstructured":"Marchetti C, Swartzwelter B, Gamboni F, Neff CP, Richter K, Azam T, et al. OLT1177, a beta-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc Natl Acad Sci USA. 2018;115:E1530\u2013E1539.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1054_CR33","doi-asserted-by":"publisher","first-page":"104348","DOI":"10.1016\/j.phrs.2019.104348","volume":"147","author":"J Wu","year":"2019","unstructured":"Wu J, Luo Y, Jiang Q, Li S, Huang W, Xiang L, et al. Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1. Pharmacol Res. 2019;147:104348.","journal-title":"Pharmacol Res"},{"key":"1054_CR34","doi-asserted-by":"publisher","first-page":"707610","DOI":"10.3389\/fphar.2021.707610","volume":"12","author":"X Xu","year":"2021","unstructured":"Xu X, Li J, Long X, Tao S, Yu X, Ruan X, et al. C646 protects against DSS-induced colitis model by targeting NLRP3 inflammasome. Front Pharmacol. 2021;12:707610.","journal-title":"Front Pharmacol"},{"key":"1054_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237\u201341.","journal-title":"Nature."},{"key":"1054_CR36","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756\u201370.","journal-title":"Lancet."},{"key":"1054_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","volume":"10","author":"Y Zhen","year":"2019","unstructured":"Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. 2019;10:276.","journal-title":"Front Immunol"},{"key":"1054_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-394596-9.00009-3","volume":"105","author":"A Mizoguchi","year":"2012","unstructured":"Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci. 2012;105:263\u2013320.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1054_CR39","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gut.2009.197822","volume":"59","author":"C Bauer","year":"2010","unstructured":"Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut. 2010;59:1192\u20139.","journal-title":"Gut."},{"key":"1054_CR40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clim.2006.10.013","volume":"122","author":"S Watanabe","year":"2007","unstructured":"Watanabe S, Yamakawa M, Hiroaki T, Kawata S, Kimura O. Correlation of dendritic cell infiltration with active crypt inflammation in ulcerative colitis. Clin Immunol. 2007;122:288\u201397.","journal-title":"Clin Immunol"},{"key":"1054_CR41","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/aps.2017.185","volume":"39","author":"YX Yan","year":"2018","unstructured":"Yan YX, Shao MJ, Qi Q, Xu YS, Yang XQ, Zhu FH, et al. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages. Acta Pharmacol Sin. 2018;39:1633\u201344.","journal-title":"Acta Pharmacol Sin"},{"key":"1054_CR42","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2174\/1389557517666170425105727","volume":"17","author":"E Studzinska-Sroka","year":"2017","unstructured":"Studzinska-Sroka E, Galanty A, Bylka W. Atranorin - an interesting lichen secondary metabolite. Mini Rev Med Chem. 2017;17:1633\u201345.","journal-title":"Mini Rev Med Chem"},{"key":"1054_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11929","volume":"7","author":"MS Dick","year":"2016","unstructured":"Dick MS, Sborgi L, Ruhl S, Hiller S, Broz P. ASC filament formation serves as a signal amplification mechanism for inflammasomes. Nat Commun. 2016;7:11929.","journal-title":"Nat Commun"},{"key":"1054_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4209","volume":"5","author":"N Van Opdenbosch","year":"2014","unstructured":"Van Opdenbosch N, Gurung P, Vande Walle L, Fossoul A, Kanneganti T-D, Lamkanfi M. Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation. Nat Commun. 2014;5:3209.","journal-title":"Nat Commun"},{"key":"1054_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nchembio.2229","volume":"13","author":"MC Okondo","year":"2017","unstructured":"Okondo MC, Johnson DC, Sridharan R, Go EB, Chui AJ, Wang MS, et al. DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis. Nat Chem Biol. 2017;13:46\u201353.","journal-title":"Nat Chem Biol"},{"key":"1054_CR46","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","volume":"156","author":"A Lu","year":"2014","unstructured":"Lu A, Magupalli VG, Ruan J, Yin Q, Atianand MK, Vos MR, et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell. 2014;156:1193\u2013206.","journal-title":"Cell."},{"key":"1054_CR47","doi-asserted-by":"publisher","first-page":"13237","DOI":"10.1073\/pnas.1507579112","volume":"112","author":"L Sborgi","year":"2015","unstructured":"Sborgi L, Ravotti F, Dandey VP, Dick MS, Mazur A, Reckel S, et al. Structure and assembly of the mouse ASC inflammasome by combined NMR spectroscopy and cryo-electron microscopy. Proc Natl Acad Sci USA. 2015;112:13237\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1054_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep38622","volume":"6","author":"HE Lee","year":"2016","unstructured":"Lee HE, Yang G, Kim ND, Jeong S, Jung Y, Choi JY, et al. Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout. Sci Rep. 2016;6:38622.","journal-title":"Sci Rep"},{"key":"1054_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01826-0","volume":"17","author":"HL Desu","year":"2020","unstructured":"Desu HL, Plastini M, Illiano P, Bramlett HM, Dietrich WD, de Rivero Vaccari JP, et al. IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis. J Neuroinflammation. 2020;17:143.","journal-title":"J Neuroinflammation"},{"key":"1054_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.trsl.2022.06.016","volume":"251","author":"JP de Rivero Vaccari","year":"2023","unstructured":"de Rivero Vaccari JP, Mim C, Hadad R, Cyr B, Stefansdottir TA, Keane RW. Mechanism of action of IC100, a humanized IgG4 monoclonal antibody targeting apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC). Transl Res. 2023;251:27\u201340.","journal-title":"Transl Res"},{"key":"1054_CR51","doi-asserted-by":"publisher","first-page":"107880","DOI":"10.1016\/j.pharmthera.2021.107880","volume":"227","author":"S Shao","year":"2021","unstructured":"Shao S, Chen C, Shi G, Zhou Y, Wei Y, Fan N, et al. Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis. Pharmacol Ther. 2021;227:107880.","journal-title":"Pharmacol Ther"},{"key":"1054_CR52","doi-asserted-by":"publisher","first-page":"e155563","DOI":"10.1172\/jci.insight.155563","volume":"7","author":"WE Barclay","year":"2022","unstructured":"Barclay WE, Aggarwal N, Deerhake ME, Inoue M, Nonaka T, Nozaki K, et al. The AIM2 inflammasome is activated in astrocytes during the late phase of EAE. JCI Insight. 2022;7:e155563.","journal-title":"JCI Insight"},{"key":"1054_CR53","doi-asserted-by":"publisher","first-page":"e1004150","DOI":"10.1371\/journal.ppat.1004150","volume":"10","author":"A Dumas","year":"2014","unstructured":"Dumas A, Amiable N, de Rivero Vaccari JP, Chae JJ, Keane RW, Lacroix S, et al. The inflammasome pyrin contributes to pertussis toxin-induced IL-1beta synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis. PLoS Pathog. 2014;10:e1004150.","journal-title":"PLoS Pathog"},{"key":"1054_CR54","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/rheumatology\/keu318","volume":"54","author":"CA Yang","year":"2015","unstructured":"Yang CA, Huang ST, Chiang BL. Sex-dependent differential activation of NLRP3 and AIM2 inflammasomes in SLE macrophages. Rheumatology. 2015;54:324\u201331.","journal-title":"Rheumatology"},{"key":"1054_CR55","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519\u201350.","journal-title":"Annu Rev Immunol"},{"key":"1054_CR56","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1053\/j.gastro.2020.06.038","volume":"159","author":"M Rawat","year":"2020","unstructured":"Rawat M, Nighot M, Al-Sadi R, Gupta Y, Viszwapriya D, Yochum G, et al. IL1B increases intestinal tight junction permeability by up-regulation of MIR200C-3p, which degrades occludin mRNA. Gastroenterology. 2020;159:1375\u201389.","journal-title":"Gastroenterology."},{"key":"1054_CR57","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.4049\/jimmunol.178.7.4641","volume":"178","author":"RM Al-Sadi","year":"2007","unstructured":"Al-Sadi RM, Ma TY. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol. 2007;178:4641\u20139.","journal-title":"J Immunol"},{"key":"1054_CR58","doi-asserted-by":"publisher","first-page":"767456","DOI":"10.3389\/fimmu.2021.767456","volume":"12","author":"LW Kaminsky","year":"2021","unstructured":"Kaminsky LW, Al-Sadi R, Ma TY. IL-1beta and the intestinal epithelial tight junction barrier. Front Immunol. 2021;12:767456.","journal-title":"Front Immunol"},{"key":"1054_CR59","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14:573\u201384.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1054_CR60","doi-asserted-by":"publisher","first-page":"e13452","DOI":"10.15252\/emmm.202013452","volume":"13","author":"D Watanabe","year":"2021","unstructured":"Watanabe D, Guo Y, Kamada N. Interaction between the inflammasome and commensal microorganisms in gastrointestinal health and disease. EMBO Mol Med. 2021;13:e13452.","journal-title":"EMBO Mol Med"},{"key":"1054_CR61","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s11274-007-9580-7","volume":"24","author":"B Rankovic","year":"2008","unstructured":"Rankovic B, Misic M, Sukdolak S. The antimicrobial activity of substances derived from the lichens Physcia aipolia, Umbilicaria polyphylla, Parmelia caperata and Hypogymnia physodes. World J Microbiol Biotechnol. 2008;24:1239\u201342.","journal-title":"World J Microbiol Biotechnol"},{"key":"1054_CR62","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/plants11131624","volume":"11","author":"A Kocovic","year":"2022","unstructured":"Kocovic A, Jeremic J, Bradic J, Sovrlic M, Tomovic J, Vasiljevic P, et al. Phytochemical analysis, antioxidant, antimicrobial, and cytotoxic activity of different extracts of Xanthoparmelia stenophylla Lichen from Stara Planina, Serbia. Plants. 2022;11:1624.","journal-title":"Plants"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01054-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T07:04:57Z","timestamp":1690441497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01054-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1054"],"URL":"https:\/\/doi.org\/10.1038\/s41401-023-01054-1","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}